pcDNA3-SARS-CoV-2-S-RBD-sfGFP Citations (17)
Originally described in: Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.Chan KK, Dorosky D, Sharma P, Abbasi SA, Dye JM, Kranz DM, Herbert AS, Procko E Science. 2020 Sep 4;369(6508):1261-1265. doi: 10.1126/science.abc0870. Epub 2020 Aug 4. PubMed Journal
Articles Citing pcDNA3-SARS-CoV-2-S-RBD-sfGFP
| Articles |
|---|
| The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2. Procko E. bioRxiv. 2020 May 11. doi: 10.1101/2020.03.16.994236. PubMed |
| Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor. Suh JS, Kim HS, Kim TJ. Sens Actuators B Chem. 2021 May 1;334:129663. doi: 10.1016/j.snb.2021.129663. Epub 2021 Feb 16. PubMed |
| Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion. Kim TY, Jeon S, Jang Y, Gotina L, Won J, Ju YH, Kim S, Jang MW, Won W, Park MG, Pae AN, Han S, Kim S, Lee CJ. Exp Mol Med. 2021 May;53(5):956-972. doi: 10.1038/s12276-021-00624-9. Epub 2021 May 25. PubMed |
| Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2. Higuchi Y, Suzuki T, Arimori T, Ikemura N, Mihara E, Kirita Y, Ohgitani E, Mazda O, Motooka D, Nakamura S, Sakai Y, Itoh Y, Sugihara F, Matsuura Y, Matoba S, Okamoto T, Takagi J, Hoshino A. Nat Commun. 2021 Jun 21;12(1):3802. doi: 10.1038/s41467-021-24013-y. PubMed |
Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection.
Shukla N, Roelle SM, Suzart VG, Bruchez AM, Matreyek KA.
PLoS Pathog. 2021 Jul 16;17(7):e1009715. doi: 10.1371/journal.ppat.1009715. eCollection 2021 Jul.
PubMed
Associated Plasmids |
| GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2. Tsai MS, Yang YH, Lin YS, Chang GH, Hsu CM, Yeh RA, Shu LH, Cheng YC, Liu HT, Wu YH, Wu YH, Shen RC, Wu CY. Biomed Pharmacother. 2021 Oct;142:112011. doi: 10.1016/j.biopha.2021.112011. Epub 2021 Aug 5. PubMed |
| Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar Affinity. Havranek B, Chan KK, Wu A, Procko E, Islam SM. J Chem Inf Model. 2021 Sep 27;61(9):4656-4669. doi: 10.1021/acs.jcim.1c00783. Epub 2021 Aug 24. PubMed |
| Associations between Allelic Variants of the Human IgH 3' Regulatory Region 1 and the Immune Response to BNT162b2 mRNA Vaccine. Colucci M, De Santis E, Totti B, Miroballo M, Tamiro F, Rossi G, Piepoli A, De Vincentis G, Greco A, Mangia A, Cianci R, Di Mauro L, Miscio G, Giambra V. Vaccines (Basel). 2021 Oct 19;9(10). pii: vaccines9101207. doi: 10.3390/vaccines9101207. PubMed |
| COVID-19 Specific Immune Markers Revealed by Single Cell Phenotypic Profiling. Sansico F, Miroballo M, Bianco DS, Tamiro F, Colucci M, Santis E, Rossi G, Rosati J, Di Mauro L, Miscio G, Mazza T, Vescovi AL, Mazzoccoli G, Giambra V, On Behalf Of Css-Covid Group. Biomedicines. 2021 Nov 29;9(12). pii: biomedicines9121794. doi: 10.3390/biomedicines9121794. PubMed |
| The dynamic nature of the coronavirus receptor, angiotensin-converting enzyme 2 (ACE2) in differentiating airway epithelia. Manna VJ, Choi H, Rotoli SM, Caradonna SJ. BBA Adv. 2022;2:100044. doi: 10.1016/j.bbadva.2022.100044. Epub 2022 Feb 12. PubMed |
| Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations. Tsai MS, Shih WT, Yang YH, Lin YS, Chang GH, Hsu CM, Yeh RA, Shu LH, Cheng YC, Liu HT, Wu YH, Wu YH, Shen RC, Wu CY. Biomed Pharmacother. 2022 May;149:112802. doi: 10.1016/j.biopha.2022.112802. Epub 2022 Mar 9. PubMed |
| Femtomolar detection of SARS-CoV-2 via peptide beacons integrated on a miniaturized TIRF microscope. Tripathy SP, Ponnapati M, Bhat S, Jacobson J, Chatterjee P. Sci Adv. 2022 Aug 26;8(34):eabn2378. doi: 10.1126/sciadv.abn2378. Epub 2022 Aug 24. PubMed |
| Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii. Kiefer AM, Niemeyer J, Probst A, Erkel G, Schroda M. Front Plant Sci. 2022 Sep 20;13:988870. doi: 10.3389/fpls.2022.988870. eCollection 2022. PubMed |
| Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern. Kim TY, Jeon S, Ko M, Du YE, Son SR, Jang DS, Kim S, Lee CJ. Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0120122. doi: 10.1128/aac.01201-22. Epub 2022 Nov 14. PubMed |
| Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model. Wahba MA, Mofed D, Ghareeb DA, Omran JI, Salem TZ. J Genet Eng Biotechnol. 2023 Feb 9;21(1):16. doi: 10.1186/s43141-023-00472-2. PubMed |
| The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution. Wu CY, Yang YH, Lin YS, Shu LH, Cheng YC, Liu HT, Lin YY, Lee IY, Shih WT, Yang PR, Tsai YY, Chang GH, Hsu CM, Yeh RA, Wu YH, Wu YH, Shen RC, Tsai MS. Heliyon. 2023 Jul 3;9(7):e17701. doi: 10.1016/j.heliyon.2023.e17701. eCollection 2023 Jul. PubMed |
| SARS-CoV-2 spike receptor-binding domain is internalized and promotes protein ISGylation in human induced pluripotent stem cell-derived cardiomyocytes. Okuno S, Higo S, Kondo T, Shiba M, Kameda S, Inoue H, Tabata T, Ogawa S, Morishita Y, Sun C, Ishino S, Honda T, Miyagawa S, Sakata Y. Sci Rep. 2023 Dec 4;13(1):21397. doi: 10.1038/s41598-023-48084-7. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.